基于CT影像组学的智能临床决策支持系统用于胃癌淋巴结转移术前预测
本研究回顾性收集490例胃癌患者的临床病理和静脉期CT影像数据,提取影像组学特征并用支持向量机建模,在326例训练验证集和164例测试集中评估决策支持系统(DSS)预测淋巴结转移的性能。DSS在训练验证集AUC为0.824(95%CI 0.804-0.847),测试集AUC为0.764(95%CI 0.699-0.833),准确率均优于传统分期标准。基于13个「值得关注」影像组学特征的DSS似乎是有前景的胃癌淋巴结状态术前预测工具。
要点
- DSS在训练验证集预测淋巴结转移的AUC为0.824(95%CI 0.804-0.847),测试集为0.764(95%CI 0.699-0.833)。
- DSS准确率在训练验证集为76.4% vs 传统分期标准63.5%,测试集为71.3% vs 63.2%。
- DSS基于13个「值得关注」的静脉期CT影像组学特征构建。
核心结论
- 基于13个「值得关注」影像组学特征的DSS似乎是有前景的胃癌患者淋巴结状态术前预测工具。
研究设计与样本
- 回顾性研究,纳入2002年1月至2016年12月间490例胃癌患者,从静脉期CT图像提取影像组学特征,用支持向量机分类器在326例训练验证集建模,164例独立测试集验证,并与传统分期标准进行头对头比较。
关键影像表现/征象
- 490例患者中297例有淋巴结转移组织病理学证据,转移率60.6%。
- DSS预测淋巴结阳性的校准图显示预测概率与观察概率一致性良好。
诊断标准与关键数值
- DSS预测淋巴结阳性的AUC在训练验证数据为0.824(95%CI 0.804-0.847),在测试数据为0.764(95%CI 0.699-0.833)。
- DSS准确率在训练验证数据为76.4%,传统分期标准为63.5%。
- DSS准确率在测试数据为71.3%,传统分期标准为63.2%。
临床应用与阅片要点
- DSS在训练验证数据和测试数据中预测淋巴结转移的准确率均高于传统分期标准。
- DSS基于静脉期CT影像组学特征构建,可用于胃癌淋巴结状态的术前预测评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to develop and validate a computational clinical decision support system (DSS) on the basis of CT radiomics features for the prediction of lymph node (LN) metastasis in gastric cancer (GC) using machine learning-based analysis.
METHODS: Clinicopathologic and CT imaging data were retrospectively collected from 490 patients who were diagnosed with GC between January 2002 and December 2016. Radiomics features were extracted from venous-phase CT images. Relevant features were selected, ranked, and modeled using a support vector machine classifier in 326 training and validation data sets. A model test was performed independently in a test set (n = 164). Finally, a head-to-head comparison of the diagnostic performance of the DSS and that of the conventional staging criterion was performed.
RESULTS: Two hundred ninety-seven of the 490 patients examined had histopathologic evidence of LN metastasis, yielding a 60.6% metastatic rate. The area under the curve for predicting LN+ was 0.824 (95% confidence interval, 0.804-0.847) for the DSS in the training and validation data and 0.764 (95% confidence interval, 0.699-0.833) in the test data. The calibration plots showed good concordance between the predicted and observed probability of LN+ using the DSS approach. The DSS was better able to predict LN metastasis than the conventional staging criterion in the training and validation data (accuracy 76.4% versus 63.5%) and in the test data (accuracy 71.3% versus 63.2%) CONCLUSIONS: A DSS based on 13 "worrisome" radiomics features appears to be a promising tool for the preoperative prediction of LN status in patients with GC.
引用
- Feng QX, Liu C, Qi L, et al. An Intelligent Clinical Decision Support System for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. J Am Coll Radiol. 2019. PMID: 30733162. doi:10.1016/j.jacr.2018.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。